Yasushi Yatabe

Research interests

Publications

• The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015

  Journal of Thoracic Oncology · 2021 · https://doi.org/10.1016/j.jtho.2021.11.003

• A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee

  Journal of Thoracic Oncology · 2020 · 10.1016/j.jtho.2020.06.001

• IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy

  Journal of Thoracic Oncology · 2020 · 10.1016/j.jtho.2020.01.005

• Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer

  Journal of Thoracic Oncology · 2018 · 10.1016/j.jtho.2018.12.005

• Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors

  Journal of Thoracic Oncology · 2018 · https://doi.org/10.1016/j.jtho.2017.12.001

• PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project

  Journal of Thoracic Oncology · 2018 · https://doi.org/10.1016/j.jtho.2018.05.013

• Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

  Archives of Pathology & Laboratory Medicine · 2018 · https://doi.org/10.5858/arpa.2017-0388-cp

• The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer

  Journal of Thoracic Oncology · 2016 · https://doi.org/10.1016/j.jtho.2016.03.025

• Comprehensive genomic profiles of small cell lung cancer

  Nature · 2015 · https://doi.org/10.1038/nature14664

• The 2015 World Health Organization Classification of Lung Tumors

  Journal of Thoracic Oncology · 2015 · https://doi.org/10.1097/jto.0000000000000630

• Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation

  Nature Communications · 2014 · https://doi.org/10.1038/ncomms5999

• ABCA Transporter Gene Expression and Poor Outcome in Epithelial Ovarian Cancer

  JNCI Journal of the National Cancer Institute · 2014 · https://doi.org/10.1093/jnci/dju149

• Diagnosis of Lung Cancer in Small Biopsies and Cytology: Implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification

  Archives of Pathology & Laboratory Medicine · 2012 · 10.5858/arpa.2012-0263-ra

• Epithelial to Mesenchymal Transition in an Epidermal Growth Factor Receptor-Mutant Lung Cancer Cell Line with Acquired Resistance to Erlotinib

  Journal of Thoracic Oncology · 2011 · https://doi.org/10.1097/jto.0b013e318216ee52

• International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

  Journal of Thoracic Oncology · 2011 · https://doi.org/10.1097/jto.0b013e318206a221

• EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors

  New England Journal of Medicine · 2010 · https://doi.org/10.1056/nejmoa1007478

• Activation of MET by Gene Amplification or by Splice Mutations Deleting the Juxtamembrane Domain in Primary Resected Lung Cancers

  Journal of Thoracic Oncology · 2009 · https://doi.org/10.1097/jto.0b013e3181913e0e

• Prognostic Implication of EGFR, KRAS, and TP53 Gene Mutations in a Large Cohort of Japanese Patients with Surgically Treated Lung Adenocarcinoma

  Journal of Thoracic Oncology · 2009 · https://doi.org/10.1097/jto.0b013e3181914111

• Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

  The Lancet Oncology · 2009 · https://doi.org/10.1016/s1470-2045(09)70364-x

• Relapse-Related Molecular Signature in Lung Adenocarcinomas Identifies Patients With Dismal Prognosis

  Journal of Clinical Oncology · 2009 · https://doi.org/10.1200/jco.2008.19.7053

• Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer

  FEBS Journal · 2009 · https://doi.org/10.1111/j.1742-4658.2009.07448.x

• Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations

  Cancer Research · 2008 · https://doi.org/10.1158/0008-5472.can-08-1643

• Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer

  Cancer Science · 2007 · https://doi.org/10.1111/j.1349-7006.2007.00607.x

• Analysis of Epidermal Growth Factor Receptor Gene Mutation in Patients with Non–Small Cell Lung Cancer and Acquired Resistance to Gefitinib

  Clinical Cancer Research · 2006 · https://doi.org/10.1158/1078-0432.ccr-06-0714

• Expression Profile–Defined Classification of Lung Adenocarcinoma Shows Close Relationship With Underlying Major Genetic Changes and Clinicopathologic Behaviors

  Journal of Clinical Oncology · 2006 · https://doi.org/10.1200/jco.2005.03.8224

• Mutations of the Epidermal Growth Factor Receptor Gene Predict Prolonged Survival After Gefitinib Treatment in Patients With Non–Small-Cell Lung Cancer With Postoperative Recurrence

  Journal of Clinical Oncology · 2005 · https://doi.org/10.1200/jco.2005.00.992

• Reduced expression of Dicer associated with poor prognosis in lung cancer patients

  Cancer Science · 2005 · https://doi.org/10.1111/j.1349-7006.2005.00015.x

• EGFR Mutation Is Specific for Terminal Respiratory Unit Type Adenocarcinoma

  The American Journal of Surgical Pathology · 2005 · https://doi.org/10.1097/01.pas.0000157935.28066.35

• Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival

  Cancer Research · 2004 · https://doi.org/10.1158/0008-5472.can-04-0637

• Mutations of the Epidermal Growth Factor Receptor Gene in Lung Cancer

  Cancer Research · 2004 · https://doi.org/10.1158/0008-5472.can-04-2818

• TTF-1 Expression in Pulmonary Adenocarcinomas

  The American Journal of Surgical Pathology · 2002 · https://doi.org/10.1097/00000478-200206000-00010

• Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas.

  PubMed · 1999

• Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas.

  PubMed · 1998

Current projects

No projects listed.